Quote | Ortho Regenerative Technologies Inc (OTCMKTS:ORTIF)
Last: | $0.19615 |
---|---|
Change Percent: | 0.0% |
Open: | $0.19615 |
Close: | $0.19615 |
High: | $0.19615 |
Low: | $0.19615 |
Volume: | 5,500 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Ortho Regenerative Technologies Inc (OTCMKTS:ORTIF)
(NewsDirect) ChitogenX CEO Phil Deschamps joined Proactive's Natalie Stoberman with news of the company's latest federal grant and partnership deal with Polytechnique Montréal to expand the ORTHO- R platform in regenerative medicine. Deschamps said the company has obtained a $3,472,0...
Ortho Regenerative Technologies ( OTCQB:ORTIF ) has changed its corporate name to ChitogenX Inc. The new name to better represent company's proprietary technology platform expanded applications beyond orthopedics The company's shares are expected to begin trading on the CS...
Message Board Posts | Ortho Regenerative Technologies Inc (OTCMKTS:ORTIF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Ortho Regenerative Technologies Inc Company Name:
ORTIF Stock Symbol:
OTCMKTS Market:
(NewsDirect) ChitogenX CEO Phil Deschamps joined Proactive's Natalie Stoberman with news of the company's latest federal grant and partnership deal with Polytechnique Montréal to expand the ORTHO- R platform in regenerative medicine. Deschamps said the company has obtained a $3,472,0...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX Canada NewsWire New Name to better represent Company's proprietary technology platform expanded applications beyond orthopedics MONTREAL , Sept. 7, 2022 /CNW Telbec/ ...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Canada NewsWire First patient surgery completed; additional surgeries already scheduled 8 clinical centres now fully initi...